Global Peripheral Vasodilator Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 104

Published Date: 14 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Peripheral Vasodilator Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Peripheral vasodilator drugs are a class of medications used to treat conditions related to the constriction of blood vessels in the peripheral tissues of the body. These drugs work by relaxing the smooth muscles in the walls of blood vessels.

This report is a detailed and comprehensive analysis for global Peripheral Vasodilator Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Peripheral Vasodilator Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Peripheral Vasodilator Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Peripheral Vasodilator Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Peripheral Vasodilator Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Peripheral Vasodilator Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Peripheral Vasodilator Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Inc., Novartis AG, GSK plc, AstraZeneca and Merck & Co., Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Peripheral Vasodilator Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Calcium Channel Blockers
    Alpha-adrenergic Blockers
    Potassium Channel Activators
    Others

Market segment by Application
    Hospital
    Retail Pharmacies
    Others

Major players covered
    Pfizer, Inc.
    Novartis AG
    GSK plc
    AstraZeneca
    Merck & Co., Inc.
    Sanofi
    Bayer AG
    Abbott Laboratories
    Bristol-Myers Squibb Company
    Boehringer Ingelheim International GmbH
    Teva Pharmaceutical Industries Ltd.
    Viatris, Inc.
    Sun Pharmaceutical Industries Ltd.
    Lupin

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peripheral Vasodilator Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Peripheral Vasodilator Drugs, with price, sales, revenue and global market share of Peripheral Vasodilator Drugs from 2018 to 2023.
Chapter 3, the Peripheral Vasodilator Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peripheral Vasodilator Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Peripheral Vasodilator Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Peripheral Vasodilator Drugs.
Chapter 14 and 15, to describe Peripheral Vasodilator Drugs sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Peripheral Vasodilator Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Peripheral Vasodilator Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Calcium Channel Blockers
        1.3.3 Alpha-adrenergic Blockers
        1.3.4 Potassium Channel Activators
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Peripheral Vasodilator Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Retail Pharmacies
        1.4.4 Others
    1.5 Global Peripheral Vasodilator Drugs Market Size & Forecast
        1.5.1 Global Peripheral Vasodilator Drugs Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Peripheral Vasodilator Drugs Sales Quantity (2018-2029)
        1.5.3 Global Peripheral Vasodilator Drugs Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Pfizer, Inc.
        2.1.1 Pfizer, Inc. Details
        2.1.2 Pfizer, Inc. Major Business
        2.1.3 Pfizer, Inc. Peripheral Vasodilator Drugs Product and Services
        2.1.4 Pfizer, Inc. Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer, Inc. Recent Developments/Updates
    2.2 Novartis AG
        2.2.1 Novartis AG Details
        2.2.2 Novartis AG Major Business
        2.2.3 Novartis AG Peripheral Vasodilator Drugs Product and Services
        2.2.4 Novartis AG Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Novartis AG Recent Developments/Updates
    2.3 GSK plc
        2.3.1 GSK plc Details
        2.3.2 GSK plc Major Business
        2.3.3 GSK plc Peripheral Vasodilator Drugs Product and Services
        2.3.4 GSK plc Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 GSK plc Recent Developments/Updates
    2.4 AstraZeneca
        2.4.1 AstraZeneca Details
        2.4.2 AstraZeneca Major Business
        2.4.3 AstraZeneca Peripheral Vasodilator Drugs Product and Services
        2.4.4 AstraZeneca Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 AstraZeneca Recent Developments/Updates
    2.5 Merck & Co., Inc.
        2.5.1 Merck & Co., Inc. Details
        2.5.2 Merck & Co., Inc. Major Business
        2.5.3 Merck & Co., Inc. Peripheral Vasodilator Drugs Product and Services
        2.5.4 Merck & Co., Inc. Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Merck & Co., Inc. Recent Developments/Updates
    2.6 Sanofi
        2.6.1 Sanofi Details
        2.6.2 Sanofi Major Business
        2.6.3 Sanofi Peripheral Vasodilator Drugs Product and Services
        2.6.4 Sanofi Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Sanofi Recent Developments/Updates
    2.7 Bayer AG
        2.7.1 Bayer AG Details
        2.7.2 Bayer AG Major Business
        2.7.3 Bayer AG Peripheral Vasodilator Drugs Product and Services
        2.7.4 Bayer AG Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Bayer AG Recent Developments/Updates
    2.8 Abbott Laboratories
        2.8.1 Abbott Laboratories Details
        2.8.2 Abbott Laboratories Major Business
        2.8.3 Abbott Laboratories Peripheral Vasodilator Drugs Product and Services
        2.8.4 Abbott Laboratories Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Abbott Laboratories Recent Developments/Updates
    2.9 Bristol-Myers Squibb Company
        2.9.1 Bristol-Myers Squibb Company Details
        2.9.2 Bristol-Myers Squibb Company Major Business
        2.9.3 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product and Services
        2.9.4 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Bristol-Myers Squibb Company Recent Developments/Updates
    2.10 Boehringer Ingelheim International GmbH
        2.10.1 Boehringer Ingelheim International GmbH Details
        2.10.2 Boehringer Ingelheim International GmbH Major Business
        2.10.3 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product and Services
        2.10.4 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
    2.11 Teva Pharmaceutical Industries Ltd.
        2.11.1 Teva Pharmaceutical Industries Ltd. Details
        2.11.2 Teva Pharmaceutical Industries Ltd. Major Business
        2.11.3 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services
        2.11.4 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
    2.12 Viatris, Inc.
        2.12.1 Viatris, Inc. Details
        2.12.2 Viatris, Inc. Major Business
        2.12.3 Viatris, Inc. Peripheral Vasodilator Drugs Product and Services
        2.12.4 Viatris, Inc. Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Viatris, Inc. Recent Developments/Updates
    2.13 Sun Pharmaceutical Industries Ltd.
        2.13.1 Sun Pharmaceutical Industries Ltd. Details
        2.13.2 Sun Pharmaceutical Industries Ltd. Major Business
        2.13.3 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services
        2.13.4 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
    2.14 Lupin
        2.14.1 Lupin Details
        2.14.2 Lupin Major Business
        2.14.3 Lupin Peripheral Vasodilator Drugs Product and Services
        2.14.4 Lupin Peripheral Vasodilator Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Lupin Recent Developments/Updates

3 Competitive Environment: Peripheral Vasodilator Drugs by Manufacturer
    3.1 Global Peripheral Vasodilator Drugs Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Peripheral Vasodilator Drugs Revenue by Manufacturer (2018-2023)
    3.3 Global Peripheral Vasodilator Drugs Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Peripheral Vasodilator Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Peripheral Vasodilator Drugs Manufacturer Market Share in 2022
        3.4.2 Top 6 Peripheral Vasodilator Drugs Manufacturer Market Share in 2022
    3.5 Peripheral Vasodilator Drugs Market: Overall Company Footprint Analysis
        3.5.1 Peripheral Vasodilator Drugs Market: Region Footprint
        3.5.2 Peripheral Vasodilator Drugs Market: Company Product Type Footprint
        3.5.3 Peripheral Vasodilator Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Peripheral Vasodilator Drugs Market Size by Region
        4.1.1 Global Peripheral Vasodilator Drugs Sales Quantity by Region (2018-2029)
        4.1.2 Global Peripheral Vasodilator Drugs Consumption Value by Region (2018-2029)
        4.1.3 Global Peripheral Vasodilator Drugs Average Price by Region (2018-2029)
    4.2 North America Peripheral Vasodilator Drugs Consumption Value (2018-2029)
    4.3 Europe Peripheral Vasodilator Drugs Consumption Value (2018-2029)
    4.4 Asia-Pacific Peripheral Vasodilator Drugs Consumption Value (2018-2029)
    4.5 South America Peripheral Vasodilator Drugs Consumption Value (2018-2029)
    4.6 Middle East and Africa Peripheral Vasodilator Drugs Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2029)
    5.2 Global Peripheral Vasodilator Drugs Consumption Value by Type (2018-2029)
    5.3 Global Peripheral Vasodilator Drugs Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2029)
    6.2 Global Peripheral Vasodilator Drugs Consumption Value by Application (2018-2029)
    6.3 Global Peripheral Vasodilator Drugs Average Price by Application (2018-2029)

7 North America
    7.1 North America Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2029)
    7.2 North America Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2029)
    7.3 North America Peripheral Vasodilator Drugs Market Size by Country
        7.3.1 North America Peripheral Vasodilator Drugs Sales Quantity by Country (2018-2029)
        7.3.2 North America Peripheral Vasodilator Drugs Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2029)
    8.2 Europe Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2029)
    8.3 Europe Peripheral Vasodilator Drugs Market Size by Country
        8.3.1 Europe Peripheral Vasodilator Drugs Sales Quantity by Country (2018-2029)
        8.3.2 Europe Peripheral Vasodilator Drugs Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Peripheral Vasodilator Drugs Market Size by Region
        9.3.1 Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Peripheral Vasodilator Drugs Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2029)
    10.2 South America Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2029)
    10.3 South America Peripheral Vasodilator Drugs Market Size by Country
        10.3.1 South America Peripheral Vasodilator Drugs Sales Quantity by Country (2018-2029)
        10.3.2 South America Peripheral Vasodilator Drugs Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Peripheral Vasodilator Drugs Market Size by Country
        11.3.1 Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Peripheral Vasodilator Drugs Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Peripheral Vasodilator Drugs Market Drivers
    12.2 Peripheral Vasodilator Drugs Market Restraints
    12.3 Peripheral Vasodilator Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Peripheral Vasodilator Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Peripheral Vasodilator Drugs
    13.3 Peripheral Vasodilator Drugs Production Process
    13.4 Peripheral Vasodilator Drugs Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Peripheral Vasodilator Drugs Typical Distributors
    14.3 Peripheral Vasodilator Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Peripheral Vasodilator Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Peripheral Vasodilator Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
    Table 4. Pfizer, Inc. Major Business
    Table 5. Pfizer, Inc. Peripheral Vasodilator Drugs Product and Services
    Table 6. Pfizer, Inc. Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Pfizer, Inc. Recent Developments/Updates
    Table 8. Novartis AG Basic Information, Manufacturing Base and Competitors
    Table 9. Novartis AG Major Business
    Table 10. Novartis AG Peripheral Vasodilator Drugs Product and Services
    Table 11. Novartis AG Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Novartis AG Recent Developments/Updates
    Table 13. GSK plc Basic Information, Manufacturing Base and Competitors
    Table 14. GSK plc Major Business
    Table 15. GSK plc Peripheral Vasodilator Drugs Product and Services
    Table 16. GSK plc Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. GSK plc Recent Developments/Updates
    Table 18. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 19. AstraZeneca Major Business
    Table 20. AstraZeneca Peripheral Vasodilator Drugs Product and Services
    Table 21. AstraZeneca Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. AstraZeneca Recent Developments/Updates
    Table 23. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
    Table 24. Merck & Co., Inc. Major Business
    Table 25. Merck & Co., Inc. Peripheral Vasodilator Drugs Product and Services
    Table 26. Merck & Co., Inc. Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Merck & Co., Inc. Recent Developments/Updates
    Table 28. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 29. Sanofi Major Business
    Table 30. Sanofi Peripheral Vasodilator Drugs Product and Services
    Table 31. Sanofi Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Sanofi Recent Developments/Updates
    Table 33. Bayer AG Basic Information, Manufacturing Base and Competitors
    Table 34. Bayer AG Major Business
    Table 35. Bayer AG Peripheral Vasodilator Drugs Product and Services
    Table 36. Bayer AG Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Bayer AG Recent Developments/Updates
    Table 38. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
    Table 39. Abbott Laboratories Major Business
    Table 40. Abbott Laboratories Peripheral Vasodilator Drugs Product and Services
    Table 41. Abbott Laboratories Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Abbott Laboratories Recent Developments/Updates
    Table 43. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
    Table 44. Bristol-Myers Squibb Company Major Business
    Table 45. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product and Services
    Table 46. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Bristol-Myers Squibb Company Recent Developments/Updates
    Table 48. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
    Table 49. Boehringer Ingelheim International GmbH Major Business
    Table 50. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product and Services
    Table 51. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Boehringer Ingelheim International GmbH Recent Developments/Updates
    Table 53. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
    Table 54. Teva Pharmaceutical Industries Ltd. Major Business
    Table 55. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services
    Table 56. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
    Table 58. Viatris, Inc. Basic Information, Manufacturing Base and Competitors
    Table 59. Viatris, Inc. Major Business
    Table 60. Viatris, Inc. Peripheral Vasodilator Drugs Product and Services
    Table 61. Viatris, Inc. Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Viatris, Inc. Recent Developments/Updates
    Table 63. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
    Table 64. Sun Pharmaceutical Industries Ltd. Major Business
    Table 65. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services
    Table 66. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
    Table 68. Lupin Basic Information, Manufacturing Base and Competitors
    Table 69. Lupin Major Business
    Table 70. Lupin Peripheral Vasodilator Drugs Product and Services
    Table 71. Lupin Peripheral Vasodilator Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Lupin Recent Developments/Updates
    Table 73. Global Peripheral Vasodilator Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 74. Global Peripheral Vasodilator Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 75. Global Peripheral Vasodilator Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 76. Market Position of Manufacturers in Peripheral Vasodilator Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 77. Head Office and Peripheral Vasodilator Drugs Production Site of Key Manufacturer
    Table 78. Peripheral Vasodilator Drugs Market: Company Product Type Footprint
    Table 79. Peripheral Vasodilator Drugs Market: Company Product Application Footprint
    Table 80. Peripheral Vasodilator Drugs New Market Entrants and Barriers to Market Entry
    Table 81. Peripheral Vasodilator Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 82. Global Peripheral Vasodilator Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 83. Global Peripheral Vasodilator Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 84. Global Peripheral Vasodilator Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 85. Global Peripheral Vasodilator Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 86. Global Peripheral Vasodilator Drugs Average Price by Region (2018-2023) & (US$/Unit)
    Table 87. Global Peripheral Vasodilator Drugs Average Price by Region (2024-2029) & (US$/Unit)
    Table 88. Global Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 89. Global Peripheral Vasodilator Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 90. Global Peripheral Vasodilator Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 91. Global Peripheral Vasodilator Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 92. Global Peripheral Vasodilator Drugs Average Price by Type (2018-2023) & (US$/Unit)
    Table 93. Global Peripheral Vasodilator Drugs Average Price by Type (2024-2029) & (US$/Unit)
    Table 94. Global Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 95. Global Peripheral Vasodilator Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 96. Global Peripheral Vasodilator Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 97. Global Peripheral Vasodilator Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 98. Global Peripheral Vasodilator Drugs Average Price by Application (2018-2023) & (US$/Unit)
    Table 99. Global Peripheral Vasodilator Drugs Average Price by Application (2024-2029) & (US$/Unit)
    Table 100. North America Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 101. North America Peripheral Vasodilator Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 102. North America Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 103. North America Peripheral Vasodilator Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 104. North America Peripheral Vasodilator Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 105. North America Peripheral Vasodilator Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 106. North America Peripheral Vasodilator Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 107. North America Peripheral Vasodilator Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 108. Europe Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 109. Europe Peripheral Vasodilator Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 110. Europe Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 111. Europe Peripheral Vasodilator Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 112. Europe Peripheral Vasodilator Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 113. Europe Peripheral Vasodilator Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 114. Europe Peripheral Vasodilator Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 115. Europe Peripheral Vasodilator Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 116. Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 117. Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 118. Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 119. Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 120. Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 121. Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 122. Asia-Pacific Peripheral Vasodilator Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 123. Asia-Pacific Peripheral Vasodilator Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 124. South America Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 125. South America Peripheral Vasodilator Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 126. South America Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 127. South America Peripheral Vasodilator Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 128. South America Peripheral Vasodilator Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 129. South America Peripheral Vasodilator Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 130. South America Peripheral Vasodilator Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 131. South America Peripheral Vasodilator Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 132. Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 133. Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 134. Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 135. Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 136. Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 137. Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 138. Middle East & Africa Peripheral Vasodilator Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 139. Middle East & Africa Peripheral Vasodilator Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 140. Peripheral Vasodilator Drugs Raw Material
    Table 141. Key Manufacturers of Peripheral Vasodilator Drugs Raw Materials
    Table 142. Peripheral Vasodilator Drugs Typical Distributors
    Table 143. Peripheral Vasodilator Drugs Typical Customers
List of Figures
    Figure 1. Peripheral Vasodilator Drugs Picture
    Figure 2. Global Peripheral Vasodilator Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Peripheral Vasodilator Drugs Consumption Value Market Share by Type in 2022
    Figure 4. Calcium Channel Blockers Examples
    Figure 5. Alpha-adrenergic Blockers Examples
    Figure 6. Potassium Channel Activators Examples
    Figure 7. Others Examples
    Figure 8. Global Peripheral Vasodilator Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Peripheral Vasodilator Drugs Consumption Value Market Share by Application in 2022
    Figure 10. Hospital Examples
    Figure 11. Retail Pharmacies Examples
    Figure 12. Others Examples
    Figure 13. Global Peripheral Vasodilator Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Peripheral Vasodilator Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Peripheral Vasodilator Drugs Sales Quantity (2018-2029) & (K Units)
    Figure 16. Global Peripheral Vasodilator Drugs Average Price (2018-2029) & (US$/Unit)
    Figure 17. Global Peripheral Vasodilator Drugs Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Peripheral Vasodilator Drugs Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Peripheral Vasodilator Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Peripheral Vasodilator Drugs Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Peripheral Vasodilator Drugs Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Peripheral Vasodilator Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Peripheral Vasodilator Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Peripheral Vasodilator Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Peripheral Vasodilator Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Peripheral Vasodilator Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Peripheral Vasodilator Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Peripheral Vasodilator Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Peripheral Vasodilator Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Peripheral Vasodilator Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Peripheral Vasodilator Drugs Average Price by Type (2018-2029) & (US$/Unit)
    Figure 32. Global Peripheral Vasodilator Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Peripheral Vasodilator Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Peripheral Vasodilator Drugs Average Price by Application (2018-2029) & (US$/Unit)
    Figure 35. North America Peripheral Vasodilator Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Peripheral Vasodilator Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Peripheral Vasodilator Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Peripheral Vasodilator Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Peripheral Vasodilator Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Peripheral Vasodilator Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Peripheral Vasodilator Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Peripheral Vasodilator Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Peripheral Vasodilator Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Peripheral Vasodilator Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Peripheral Vasodilator Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Peripheral Vasodilator Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Peripheral Vasodilator Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Peripheral Vasodilator Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Peripheral Vasodilator Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Peripheral Vasodilator Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Peripheral Vasodilator Drugs Market Drivers
    Figure 76. Peripheral Vasodilator Drugs Market Restraints
    Figure 77. Peripheral Vasodilator Drugs Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Peripheral Vasodilator Drugs in 2022
    Figure 80. Manufacturing Process Analysis of Peripheral Vasodilator Drugs
    Figure 81. Peripheral Vasodilator Drugs Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Peripheral Vasodilator Drugs Supply, Demand and Key Producers, 2023-2029

Global Peripheral Vasodilator Drugs Supply, Demand and Key Producers, 2023-2029

date 14 Mar 2023

date Pharma & Healthcare

The global Peripheral Vasodilator Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Peripheral Vasodilator Drugs Supply, Demand and Key Producers, 2024-2030

Global Peripheral Vasodilator Drugs Supply, Demand and Key Producers, 2024-2030

date 12 Feb 2024

date Pharma & Healthcare

The global Peripheral Vasodilator Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Peripheral Vasodilator Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>